Brian Hanratty
0000-0003-4580-649X
Publication & Citation Trends
Publications
0 total
Abstract B022: LuCaP189.4_CL: a novel 2D model of AR - high, CDK12 - mutant mCRPC suitable for studies of genetic and therapeutic vulnerabilities
Cited by 0
Semantic Scholar
Abstract PR005: Epigenetically Informed Therapeutic Strategies for DNA-Hypomethylated Prostate Cancer
Cited by 0
Semantic Scholar
798 mCRPC: From Morphology to Survival
Cited by 0
Semantic Scholar
Abstract PR009: A dependency map of androgen receptor activity identifies drivers of prostate cancer growth
Cited by 0
Semantic Scholar
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer
Cited by 0
Semantic Scholar
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology
Cited by 0
Semantic Scholar
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer
Cited by 5
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(128)
Cancer, Lipids, and Metabolism
(44)
Cancer Genomics and Diagnostics
(39)
RNA modifications and cancer
(23)
Cancer-related gene regulation
(21)
Affiliations
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
University of Ulster
University of Washington
Newcastle upon Tyne Hospitals NHS Foundation Trust
Altnagelvin Area Hospital